The Certara Blog

Author: Daniel Weiner

Dr. Daniel Weiner is the Chief Scientific Officer at Certara. When he’s not helping pharma customers find cutting-edge solutions for their drug development problems, Dr. Weiner enjoys spending time outdoors hiking and skiing.

Recent Posts

How PBPK Modeling Will Make Drugs Safer, Cheaper, and More Effective

Historically, drugs have been selected using various methods (eg, biological and chemical screens). Candidate drugs were often pushed into the clinic with only a rudimentary understanding of the link between drug exposure and resultant effect(s). As a consequence, drug development has been inefficient by relying on trial and error at the clinical stage, not to […]

Read More
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog